Native name | Fushata e vaksinimit kundër Covid-19 |
---|---|
Date | 11 January 2021 – present |
Location | Albania |
Cause | COVID-19 pandemic |
Organised by | Ministry of Health and Social Protection |
Participants | 2,170,000 people as target population [1] 2,839,483 doses administered (13 May 2022) (including Albanians vaccinated abroad) [2] 1,299,743 people vaccinated with at least one dose (13 May 2022) 59.9% 57.1% 13.8% |
Website | Ministry of Health |
The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.
In the first months of the vaccination campaign, the governmental agencies targeted the health medical and administrative personnel, together with the guests and personnel of nursing homes. [3]
Albania made efforts early in the pandemic to provide a sufficient number of doses for its citizens. The first agreement was made through COVAX to provide vaccines for 20% of the total population. The agreement of about 4 million dollars with GAVI was ratified in the parliament on 21 October 2020, from where Albania became a beneficiary for the vaccine with self-financing from this program. [4] [5] In total through the COVAX mechanism, the country has provided 1,140,000 doses for about 560 thousand people or 20% of the population. The vaccines in question are to be Oxford-AstraZeneca and Pfizer-BioNTech, which both are approved by the WHO. In the first round of distribution from February to May, there are 120,000 AstraZeneca vaccines confirmed. While in the second round, April–June, 23,400 doses of Pfizer were confirmed. [6]
Seeing that this way of providing vaccines would not be able to provide a vaccine in the first days of their distribution in Europe, and since it was left out of distribution by the union as it is not a member of it, senior state officials tried to enter into a direct contract with Pfizer in late December 2020. [7]
Unlike normal times when the approval of drugs and medical devices is done by the relevant agency called the National Agency of Drugs and Medical Devices, during an epidemic and events of public health importance the approval of vaccines is under the responsibility of the government through the Ministry of Health. [8] The decisions are taken in consultation with the Central Committee of Experts, which is set up in cases of epidemics or national medical emergencies and serves as a consultative body under the Ministry of Health. The Committee is composed of experts from the ministry itself, the Institute of Public Health, the National Emergency Center, National Infectious Diseases Service, and representatives of health institutions depending on the situation. [8] Albanian state bodies have approved four vaccines so far, which are: Pfizer–BioNTech; Oxford–AstraZeneca; Sputnik V; and CoronaVac. [9]
On 1 January 2021, the Prime Minister of Albania Edi Rama announced the reaching of an agreement with the company Pfizer for a total of 500 thousand doses. [10] The arrival of vaccines from the Pfizer will be divided batches, starting with the first batch that should come at the end of January and will continue for several months. [11] However, it was later postponed to early February by the company itself due to investments to increase its production capacity. [12] Despite the direct agreement with the company, a first batch of Pfizer vaccines was delivered by an undisclosed EU member state, consisting of 975 doses. [13]
On 1 February 2021, 1,170 more doses of the Pfizer vaccine arrived in Albania. [14] [15]
As of 12 March 2021, 23,325 people got vaccinated in Albania, and 38,400 new vaccines arrived by AstraZeneca. [16] [17] An additional 40,800 doses of AstraZeneca vaccine arrived in Albania on 17 April, through the COVAX mechanism. [18]
On 21 March 2021, Albania received 10,000 doses of Sputnik V vaccine which were donated by the United Arab Emirates, while 2 days later the Parliament approved a preliminary agreement for the supply of the CoronaVac vaccine. [19] [20]
On 21 March 2021, Albania managed to provide 1 million doses through the Turkish distribution company Keymen İlaç for the CoronaVac vaccine produced by the Chinese company Sinovac Biotech. The agreement is divided into two parts, where the first part foresees the provision of 500,000 doses of vaccine within 60 days and the other half will be renegotiated afterward. The first batch of 192,000 doses was shipped on the same day of signing while another 100,000 were shipped on April 8. [21] [22] The final batch of 208,000 vaccines, part of the initial agreement, was sent on 19 April. [23] With such an amount of vaccines, Albania started on 28 March the mass vaccination of its population. [24] According to the Ministry of Health, the administered doses reach from 10 to 15 thousand daily, but the capabilities are much more, taking into account the involvement of the military medical staff. [25]
On 26 March 2021, vaccination for the elderly over 80 years began with the Sputnik V vaccine. [26] According to Rama, another 25 thousand doses of this vaccine are expected to come but did not specify whether these will be donations as the previous 10 thousand or will be purchased from the manufacturing company. [27]
Health Minister Ogerta Manastirliu announced that vaccination of ages 65+ is expected to begin within the week, and that 500,000 people will have received at least one dose within May 2021. [28]
On 18 April 2021, a quantity of 50,000 vaccines Covishield, which is the brand name of the AstraZeneca vaccine produced by the Serum Institute of India, were provided through the Vaccine Maitri initiative by the Indian Government and received at the airport by the Indian Ambassador accompanied by two Albanian ministers. The ambassador praised Albania as a friendly country, saying that an exception was made for the provision of vaccines in the country, although India itself has blocked their export due to the increase in cases. [29] [30]
On April 5, 12 19, and 26 through four deliveries, a total of 30,420 doses of the Pfizer vaccine were delivered as part of a direct contract with the company. [31] [32] [33]
On 20 April 2021, the European Commissioner for Neighbourhood and Enlargement, Olivér Várhelyi, announced that the European Union would distribute 651,000 doses of the Pfizer vaccine to the six countries of the Western Balkans, from which Albania would receive 145,000 doses. [34] Their distribution was undertaken by the Austrian Government, and deliveries will start in May and are expected to end in August. [35] [36]
On 7 April 2021, the Albanian government paved the way for an agreement to provide a preliminary amount of 50,000 of the Russian Sputnik V vaccine scheduled to arrive 10 days after the agreement was signed. [37] Although the use of the Sputnik V vaccine had started earlier with 10,000 doses donated by the United Arab Emirates, an amount of which served as well as an evaluator of the vaccine in the country. It was on 30 April 2021 that the official approval of the vaccine in Albania was announced on the official website of the Russian Direct Investment Fund, which deals with the distribution and export of the vaccine. On the same day the first shipment of 25,000 doses was made. [38] [39]
During May, four deliveries of Pfizer and BioNTech vaccine were made in Albania with a total of 50,310 of this vaccine, most of which are through bilateral contracts and the other as part of the EU assistance program for the Western Balkans. [40] [41] [42] [43] On May 4, the parliament with some normative acts paved the way for the negotiation of the second part of the contract for the provision of SinoVac vaccines and at the same time the possibility of adding other Sputnik V vaccines. [44] The first quantity of 60,000 doses from the second contract with the Turkish company that provides the vaccines produced by the Chinese SinoVac was sent on May 23 of the same month. [45]
Vaccine name | Approval progress | Quantity | Doses arrived | Vaccine approved | Began administering |
---|---|---|---|---|---|
Pfizer/BioNTech | Approved | ~3,075,000 | 735,635 | 10 January 2021 | 11 January 2021 |
Oxford-AstraZeneca | Approved | ~1,100,000 | 249,200 | 11 January 2021 | 13 March 2021 |
Sputnik V | Approved | 60,000 | 60,000 | 9 March 2021 | 26 March 2021 |
CoronaVac | Approved | 1,500,000 | 1,000,000 | 9 March 2021 | 28 March 2021 |
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
COVID-19 vaccination in Moldova started on 2 March 2021. During the COVID-19 pandemic, Moldova was very reliant on external help from other countries, having received donations of vaccines from Romania, the United Arab Emirates, Russia and China. In fact, Moldova's vaccination campaign started due to a donation from Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru Botizatu. Romania had promised earlier, on 29 December 2020, that it would help Moldova with a collaboration project which would include 200,000 vaccine doses to help Moldova combat the pandemic, but also other matters of the country. Romania subsequently made more donations on 27 March 2021 with 50,400 vaccine units; on 17 April 2021 with 132,000 vaccine doses, fulfilling its promise to Moldova; and on 7 May 2021 with 100,800 vaccine units even though this surpassed the promised 200,000 vaccine doses.
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The virus causing COVID-19 was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.